These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 111955)

  • 41. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV; Takahashi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of selenite cataract by the flavonoid fraction of Emilia sonchifolia in experimental animal models.
    Lija Y; Biju PG; Reeni A; Cibin TR; Sahasranamam V; Abraham A
    Phytother Res; 2006 Dec; 20(12):1091-5. PubMed ID: 17009203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The lens, cataracts, and galactosemia.
    Cogan DG
    N Engl J Med; 1973 Jun; 288(23):1239-40. PubMed ID: 4700558
    [No Abstract]   [Full Text] [Related]  

  • 45. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 46. Sugar cataract.
    Chylack LT
    Arch Ophthalmol; 1972 May; 87(5):595. PubMed ID: 5028100
    [No Abstract]   [Full Text] [Related]  

  • 47. Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
    Unakar NJ; Harries W; Tsui J
    Exp Eye Res; 1985 Jan; 40(1):117-26. PubMed ID: 3920063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 49. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J; Kim CS; Sohn E; Lee YM; Kim JS
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A; Mistry K; Diecke FP; Cruz E
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Slow development of rat sugar cataracts].
    Akagi Y; Tasaka H; Tanabe T; Yoshikawa T; Ikebe H; Chamoto K; Takahashi Y; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Jan; 91(1):122-6. PubMed ID: 2954440
    [No Abstract]   [Full Text] [Related]  

  • 53. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.
    Unno R; Yamaguchi T; Usui T; Kakigami T; Fukushima M; Mizuno K; Baba Y; Kurono M
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1474-8. PubMed ID: 7923471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of dietary flavonoids in amelioration of sugar induced cataractogenesis.
    Patil KK; Meshram RJ; Dhole NA; Gacche RN
    Arch Biochem Biophys; 2016 Mar; 593():1-11. PubMed ID: 26829674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin.
    Chaudhry PS; Cabrera J; Juliani HR; Varma SD
    Biochem Pharmacol; 1983 Jul; 32(13):1995-8. PubMed ID: 6409111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats.
    Ji L; Cheng L; Yang Z
    J Diabetes Res; 2017; 2017():7309816. PubMed ID: 29038789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etiology of cataracts in diabetics.
    Varma SD; Richards RD
    Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
    [No Abstract]   [Full Text] [Related]  

  • 59. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.